Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation.
Semin Reprod Med
; 28(6): 519-31, 2010 Nov.
Article
en En
| MEDLINE
| ID: mdl-21157982
The only reliable way to eliminate the risk of ovarian hyperstimulation syndrome (OHSS) is complete avoidance of gonadotropin ovarian stimulation. It could be argued that in vitro maturation (IVM) of oocytes represents the most effective strategy to prevent OHSS. IVM has been an established treatment option in many centers worldwide for over a decade. The use of IVM and natural cycle in vitro fertilization (IVF) combined with IVM can result in clinical pregnancy rates that compare to those obtained with conventional IVF. The obstetric and perinatal outcomes of IVM pregnancies are similar to those conceived from stimulated IVF or spontaneous conceptions. To date, more than a thousand healthy infants have been born without an increase in fetal abnormalities. Although IVM may not replace standard IVF, it plays an increasingly important role in assisted reproductive technology, especially in the settings of high responders and those patients at risk of OHSS.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Oocitos
/
Oogénesis
/
Síndrome de Hiperestimulación Ovárica
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Evaluation_studies
Límite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Semin Reprod Med
Asunto de la revista:
MEDICINA REPRODUTIVA
Año:
2010
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos